RA Capital Management

Latest statistics and disclosures from Ra Capital Management's latest quarterly 13F-HR filing:

Companies in the Ra Capital Management portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Ascendis Pharma A S 17.78 5.58M +3% 27.76
Wave Life Sciences Ltd shs 15.13 7.09M 18.60
Avexis 12.35 1.31M -19% 82.16
Achillion Pharmaceuticals (ACHN) 7.18 13.63M 4.59
Biohaven Pharmaceutical Holding 7.02 2.45M NEW 25.00
G1 Therapeutics 5.37 2.68M NEW 17.44
Ignyta 4.77 4.02M +291% 10.35
Esperion Therapeutics 3.88 731531 +3% 46.28
Myovant Sciences 3.77 2.81M +19% 11.70
BioCryst Pharmaceuticals (BCRX) 3.29 5.16M +47% 5.56
Ra Pharmaceuticals 2.91 1.35M 18.74
Radius Health 2.58 497157 NEW 45.23
Zogenix 2.45 1.47M -39% 14.50
Aquinox Pharmaceuticals 2.25 1.40M -36% 14.07
AVEO Pharmaceuticals (AVEO) 2.15 8.44M NEW 2.22
Acorda Therapeutics (ACOR) 2.04 900259 +83% 19.70
Akebia Therapeutics 1.38 836337 NEW 14.37
Sangamo Biosciences (SGMO) 1.26 1.25M NEW 8.80
Dicerna Pharmaceuticals 0.88 2.43M 3.17
Tg Therapeutics 0.81 700000 10.05
Kalvista Pharmaceuticals 0.50 591070 7.36
Proteon Therapeutics 0.23 1.34M NEW 1.53

Past 13F-HR SEC Filings by Ra Capital Management

View All Filings